Presence of a Clinical Pharmacist in a Cardiology Department: What Impact on the Management of Diabetic Patients Within Care Pathways? Example of Inpatient Cardiac Patients at GHPSJ
Sponsor study identifier
interventional
44
1 country
1
Study Start
March 8, 2017
Actual (reported)Primary Completion
April 28, 2017
Actual (reported)Study Completion
December 31, 2018
Actual (reported)The coverage of the diabetes is a multidisciplinary care, with practitioners' implication(hospital and liberal), and other medical and paramedical profession: doctor, pharmacist, male nurse, nutritionist, etc. In fact there is a real importance of link between hospital and general medecine outside. That's why the pharmacist's presence during the hospitalization seems to be a good alternative to make the link between hospital and the outside pharmacist where patient take his treatment. Hospital pharmacis proceed to a treatment conciliation at the entrance and at discharge. By this conciliation the aim of the study is to show and quantify the impact of pharmacist presence on therapeutic target .
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 31, 2018
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
March 8, 2017
Actual (reported)April 28, 2017
Actual (reported)June 29, 2017
Actual (reported)July 2, 2017
Actual (reported)December 31, 2018
Actual (reported)Measurement of biological test glycosylated haemoglobin evolution between the entrance and discharge
5 days
St Joseph Hospital pharmacist assess every diabetic patient hospitalized in cardiology service in term of antidiabetic treatment during the hospitalization
St Joseph Hospital pharmacist assess every diabetic patient hospitalized in cardiology service in term of antidiabetic treatment during the hospitalization
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Groupe Hospitalier Paris Saint Joseph
Paris, Île-de-France Region, 75014, France
Romain CADOR, MD
GHPSJ
44 participants (actual enrollment reported by the registry).
First Submitted
June 29, 2017
First Posted
July 2, 2017
Study Start
March 8, 2017
Actual (reported)CARdiomyopathy in Type 2 DIAbetes Mellitus
Contact the study team to confirm eligibility.
Primary Completion
April 28, 2017
Actual (reported)Study Completion
December 31, 2018
Actual (reported)Last Updated
February 4, 2019
Record last verified: 2018-08
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: